Perfuze, an Ireland-based developer of catheter-based aspiration technology for the treatment of acute ischemic stroke, ...

Perfuze announced today that it received FDA 510(k) clearance for its Zipline access catheter and secured significant funding ...

Coinciding with the FDA’s clearance for the catheter, Perfuze has also completed a €22m ($24m) financing round.

The global peripheral micro catheters market is set for substantial expansion, with sales expected to soar from USD 1,004.9 million in 2024 to an impressive USD 1,940.2 million by 2034. This growth ...

It is driven by advancements in material science and miniaturisation. The global balloon catheters market, valued at $4.4b in 2023, is projected to grow at a 6.4% CAGR, reaching $7.6b by 2032, ...

Emergen Research Logo The major Ablation Catheters market growth factors are advancements in ablation catheter technology, and minimally in ...

Johnson & Johnson MedTech’s Shockwave Medical is launching a new intravascular lithotripsy catheter in the U.S. | While ...

In addition to the FDA 510 (k) submission, Stereotaxis expects to submit both catheters for CE mark clearance in Europe this ...

A new study shed light on the large proportion of nursing home residents who have venous catheters, or intravenous (IV) lines ...

Perfuze is a medical device company headquartered in Galway, Ireland, dedicated to developing next-generation catheter-based ...

Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced FDA regulatory submission for the MAGiC Sweep™ catheter.